ArticleThoracic cancer2022

Galectin-3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2-positive breast cancer cells.

Yuqiu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.